• Latest Posts

A Dutch entrepreneur curing his ALS disease became BIO’s Superhero

Medigene plans to fund its T-cell program with €50 Millions

American Companies are Invading London’s Biotech Stock Market

Biotech to Revolutionize the Millennial Production of Carmine!

BIO2015: Over and Out!

Celyad, the new face of Cardio3, is launching an IPO on NASDAQ

ADVERTISEMENT

Servier disburses €114 Million for Taiho’s Colorectal Cancer treatment

German Viral Vector Producer SIRION pursues its American dream and opens in Boston

Innovate UK accelerates Sareum’s fight against Leukemia

Deinove to challenge the Carotenoid Business

Bayer set a strategic alliance with J. Hopkins in retinal diseases

ADVERTISEMENT